Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 9/20 | 0.67 |
| ▸ | SHBG | P04278 | 8/20 | 0.67 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.67 |
| ▸ | SERPINA6 | P08185 | 7/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 6/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.67 |
| ▸ | TSHR | P16473 | 5/20 | 0.67 |
| ▸ | MAPT | P10636 | 5/20 | 0.67 |
| ▸ | NR3C1 | P04150 | 4/20 | 0.67 |
| ▸ | PGR | P06401 | 3/20 | 0.67 |
| ▸ | AR | P10275 | 3/20 | 0.67 |
| ▸ | GPBAR1 | Q8TDU6 | 3/20 | 0.67 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.67 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.67 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL601152 | 1.00 | LMNA (0.67) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL601153 | 1.00 | LMNA (0.67) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL11766174 | 0.89 | SHBG (0.64) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL11766184 | 0.89 | SHBG (0.64) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL572119 | 0.89 | SHBG (0.77) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL11544123 | 0.89 | LMNA (0.67) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL638332 | 0.89 | SHBG (0.77) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL11544128 | 0.89 | LMNA (0.67) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL9242740 | 0.88 | SHBG (0.63) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 | |
| SCHEMBL8781737 | 0.88 | LMNA (0.69) | LMNASHBGSMN1; SMN2SERPINA6CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070014719-A1 | Steroid analogs and characterization and treatment methods | BIOVIE INC. | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070014719-A1 | Steroid analogs and characterization and treatment methods | CYP17A1, HSD17B11, HSD3B1 | LMNA 2328/4885SHBG 40/4885SMN1; SMN2 2767/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.